New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 17, 2014
07:00 EDTDVA, FMSFresenius Medical shares should be bought, says Bernstein
Bernstein notes that Fresenius' (FMS) stock has sharply underperformed versus its competitor, DaVita (DVA), since May 2012. But the firm predicts that Fresenius' core U.S. business should outperform that of DaVita going forward. Bernstein adds that it finds Fresenius' business units aside from its U.S. dialysis clinics more attractive than DaVita's businesses other than its U.S. dialysis clinics.
News For FMS;DVA From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
December 18, 2014
16:05 EDTDVADaVita appoints Joe Mello as Healthcare Partners COO
Subscribe for More Information
December 15, 2014
11:21 EDTFMSCytoSorbents enters strategic partnership with Fresenius Medical
CytoSorbents announced that they have entered into a multi-country strategic partnership with Fresenius Medical Care AG & CO KGaA to commercialize CytoSorbents' CytoSorb therapy. Under the terms of the agreement, Fresenius Medical Care will have the exclusive rights to distribute CytoSorb for critical care applications in France, Poland, Sweden, Denmark, Norway, and Finland. This multi-year agreement is subject to annual minimum guaranteed orders of CytoSorb to maintain exclusivity.
06:12 EDTDVADaVita Clinical Research, HealthCare Partners to merge, expand clinical trials
Subscribe for More Information
06:11 EDTDVADaVita Clinical Research, HealthCare Partners to merge, expand clinical trials
December 11, 2014
07:40 EDTFMSBofA/Merrill to hold a field trip
European Medtech Field Trip is being held in Copenhagen, Denmark on December 11-12.
07:13 EDTFMSDanone to discuss whether to keep or sell medical nutrition unit, Reuters says
According to a source, Danone (DANOY) will hold a board meeting today to discuss whether to keep or sell its medical nutrition business, Reuters reports. Previous reports said Danone's board would decide whether to sell the unit to Hospira (HSP) or Fresenius (FMS), with Fresenius as the possible front-runner to enter exclusive talks. Reference Link

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use